Armistice Capital »

St. Joe Company shares owned by Armistice Capital

Quarter-by-quarter ownership of St. Joe Company (JOE) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in St. Joe Company

Tip: Access up to 7 years of quarterly data

All positions including St. Joe Company held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in St. Joe Company by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $274k 4.4k 62.63

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding St. Joe Company

Fairholme Capital Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Dimensional Fund Advisors
Select Equity
Geode Capital Management
Praetorian PR
FMR
Horizon Kinetics Asset Management
First Trust Advisors
Nitor Capital Management
Gabelli Funds
Northern Trust

View all funds holding St. Joe Company